Net sales increased by 80% to SEK 92.1 million (SEK51.3 million in the previous year ) and profit after financial items increased to SEK7.6 million (SEK 1.2 million).
During that time, 11 electron beam melting, or EBM, systems were delivered, compared to four in the previous year. The company formed a strategic alliance with DiSanto Technology Inc in February and introduced a new EBM system, Arcam Q10.
“The partnership gives Arcam the ability to offer existing and new customers contract manufacturing of advanced orthopedic implants based on the Arcam EBM technology,” said Magnus René, president & CEO. “The combination of DTI’s knowledge of traditional implant manufacturing and Arcam's cutting-edge additive manufacturing technology will accelerate the implant industry’s acceptance of the EBM technology for production of orthopedic implants.”
Arcam Q10 is the first of a new range of EBM systems, developed for industrial production. It replaces Arcam A1, which was used for the additive manufacturing of orthopedic implants. Arcam Q10 reportedly offers higher productivity and resolution, improved ergonomics, and Arcam LayerQam, a proprietary and patented camera-based system for quality control of manufactured parts.
Arcam said that orders from aerospace in particular boosted profits. “The airline market is a market with very high technical requirements," René explained. "During the period, we continued to take important machine orders in this market and in particular an order for four systems from an existing customer. The potential in the aerospace industry is very large, and intensive efforts are under way to make the company ready for the volumes and requirements in the aviation industry.”
